-
Three killed in Taipei metro attacks, suspect dead
-
Seven Colombian soldiers killed in guerrilla attack: army
-
Amorim takes aim at Man Utd youth stars over 'entitlement'
-
Mercosur meets in Brazil, EU eyes January 12 trade deal
-
US Fed official says no urgency to cut rates, flags distorted data
-
Rome to charge visitors for access to Trevi Fountain
-
Spurs 'not a quick fix' for under-fire Frank
-
Poland president accuses Ukraine of not appreciating war support
-
Stocks advance with focus on central banks, tech
-
Amorim unfazed by 'Free Mainoo' T-shirt ahead of Villa clash
-
PSG penalty hero Safonov ended Intercontinental win with broken hand
-
French court rejects Shein suspension
-
'It's so much fun,' says Vonn as she milks her comeback
-
Moscow intent on pressing on in Ukraine: Putin
-
UN declares famine over in Gaza, says 'situation remains critical'
-
Guardiola 'excited' by Man City future, not pondering exit
-
Czechs name veteran coach Koubek for World Cup play-offs
-
PSG penalty hero Safonov out until next year with broken hand
-
Putin says ball in court of Russia's opponents in Ukraine talks
-
Czech Zabystran upsets Odermatt to claim Val Gardena super-G
-
NGOs fear 'catastrophic impact' of new Israel registration rules
-
US suspends green card lottery after MIT professor, Brown University killings
-
Arsenal in the 'right place' as Arteta marks six years at club
-
Sudan's El-Fasher under the RSF, destroyed and 'full of bodies'
-
From farms to court, climate-hit communities take on big polluters
-
Liverpool have 'moved on' from Salah furore, says upbeat Slot
-
Norway crown princess likely to undergo lung transplant
-
Iraq negotiates new coalition under US pressure
-
France's budget hits snag in setback for embattled PM
-
Putin hails Ukraine gains, threatens more, in annual press conference
-
US suspends green card lottery after Brown, MIT professor shootings
-
Chelsea's Maresca says Man City link '100 percent' speculation
-
Dominant Head moves into Bradman territory with fourth Adelaide ton
-
Arsenal battle to stay top of Christmas charts
-
Mexican low-cost airlines Volaris and Viva agree to merger
-
Border casinos caught in Thailand-Cambodia crossfire
-
Australia's Head slams unbeaten 142 to crush England's Ashes hopes
-
Epstein files due as US confronts long-delayed reckoning
-
'Not our enemy': Rush to rearm sparks backlash in east Germany
-
West Indies 110-0, trail by 465, after Conway's epic 227 for New Zealand
-
Arsonists target Bangladesh newspapers after student leader's death
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Tears at tribute to firefighter killed in Hong Kong blaze
-
Seahawks edge Rams in overtime thriller to seize NFC lead
-
Teenager Flagg leads Mavericks to upset of Pistons
-
Australia's Head fires quickfire 68 as England's Ashes hopes fade
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
Conway falls for 227 as New Zealand pass 500 in West Indies Test
-
'We are ghosts': Britain's migrant night workers
Featured
Last news
Mosaic Announces Preliminary Third Quarter Volumes
TAMPA, FL, DC / ACCESS Newswire / October 10, 2025 / The Mosaic Company (NYSE:MOS) today announced preliminary third quarter 2025 segment volumes. Expectations and guidance for the fourth quarter and full year will be discussed in the upcoming third quarter earnings release and conference call.
Forte Group Announces Equity Incentive Grants and Warrant Amendments
VANCOUVER, BC / ACCESS Newswire / October 10, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a next-generation beverage and nutraceutical company focused on longevity and human performance, announces that it has granted stock options ("Stock Options") and restricted share units ("RSUs") to certain directors, officers, and consultants of the Company, effective October 10, 2025 (the "Grant Date"), in accordance with its Omnibus Equity Incentive Plan (OEIP) dated January 4, 2024 (the "Plan").
IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa
Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV
TripGift(R) Unlocks Glocal Bucket List' Dreams With Launch of New Destination Gift Card SKUs and Marketplaces for Cities, Destinations and Experiences
Travel Commerce Innovation Winner delivers New York, Los Angeles, Miami, London, Paris, Dubai, Tokyo Destination Marketplaces and Bucket List Experience Packages in 103 currencies.
Genflow Biosciences PLC Announces Update on Animal Health Program
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Michelin Guide gets an appetite beyond restaurants
France's famed Michelin Guide, a reference for fine dining for more than a century, is expanding into hotel and wine recommendations as it aims to become a global lifestyle brand.
Addison Care Debuts at athenahealth 2025 Thrive Conference: 3D Virtual Caregiver Tackles Global Healthcare Crisis of Non-Adherence and Workforce Shortages
LAS CRUCES, NEW MEXICO / ACCESS Newswire / October 9, 2025 / The healthcare industry is approaching a breaking point. Across the globe, 2.7 billion people - one in every three - live with multiple chronic conditions, and the burden is climbing rapidly. Half of all treatment failures are attributed to non-adherence in the home, where most care occurs, and 40% of the world's population still lacks access to regular healthcare services. Meanwhile, a historic shortage of providers is widening: the world is already 6.4 million doctors short and 18 million nurses short, and by 2030, an estimated one-third of all remaining providers are expected to leave practice, many due to retirement but also because of burnout, injury, illness, and caregiving responsibilities of their own.
Menhaden Fisheries Coalition Responds to Inaccuracies in Osprey Story from "The SandPaper"
WASHINGTON, DC, AL / ACCESS Newswire / October 9, 2025 / The Menhaden Fisheries Coalition (MFC) is calling out an error-laden article published by The SandPaper, a newsmagazine based in Long Beach Island, New Jersey, titled "Menhaden Scarcity Leads to Bleak Outlook for Ospreys." The article is factually inaccurate, journalistically unbalanced, and overtly reliant on unsupported claims from a single advocacy group. MFC has repeatedly contacted The SandPaper's managing editor Jay Mann asking for corrections, but unfortunately, Mr. Mann has ignored our requests.
NHI Announces Third Quarter 2025 Earnings Release and Conference Call Dates
MURFREESBORO, TN / ACCESS Newswire / October 9, 2025 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2025. NHI plans to issue its earnings release after the market closes on Thursday, November 6, 2025, and will host a conference call on the following day, Friday, November 7, 2025, at 10:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the access code 136615.
Hospitals Can’t Afford to Wait - A New Model of Care is Here By Doug Duskin, CEO, Avel eCare
SIOUX FALLS, SD / ACCESS Newswire / October 9, 2025 / Across the country, the signs are clear - hospitals are closing beds, urgent care centers are cutting hours, and entire communities are losing access to critical services. It's happening in rural towns and large metro areas alike. Provider shortages are accelerating. Financial pressures are mounting. And when a hospital closes its doors, patients don't just lose a building - they lose the safety net that keeps communities alive.
Medical Care Technologies (OTC PINK:MDCE) Advances AI Research to Help Identify Early Health Risks in Skin Cancer, Vision, Wound Care, and Mental Wellness
MESA, ARIZONA / ACCESS Newswire / October 9, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a developer of artificial intelligence-powered preventive health technology, today emphasized the urgent human need driving each vertical of its AI platform - underscoring the global lives lost and affected every year to conditions that may be better managed through earlier detection and awareness.
Lexaria Bioscience Corp. Provides Strategic Update
Strategic Business Development Advisory Firm Engaged To Support New Business Development ActivitiesLexaria Awarded 4 New Patents
iTolerance, Inc. Launches Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes
Watch the first video segment here
Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group
MAULDIN, SC / ACCESS Newswire / October 9, 2025 / Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The transaction was completed as an all-cash sale.
Who is the Best Female to Male Top Surgeon?
Dr. Javad Sajan is the best female to male top surgeon
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
NAPLES, FL, AL / ACCESS Newswire / October 9, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce an exclusive distribution agreement with Energy International Development Co., Ltd. to sell Stemtech products in Taiwan, R.O.C.
New to The Street Signs PetVivo Holdings Inc. (OTCQX:PETV) to a 12-Month National Media Campaign
Partnership Includes Long-Form Broadcast Interviews, National TV Commercials, Outdoor Billboards, and Accredited Investor Events
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed a new series of orally active, non-covalent protease inhibitors with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2). This work was carried out at the University of Arizona as part of an ongoing collaboration between the Company and the University.
Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI
Serving 80% of the largest home care networks across North America, Sensi.AI is the new standard in senior care
United Premium Foods Taps Tosca Reusable Packaging to Meet Rising Demand for Fresh Pet Food
United Premium Foods leverages Tosca's reusable pet food packaging to cut labor strain, protect product, and streamline coast-to-coast delivery.
Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies
Backed by Victory Square, Pawsible combines capital, incubation, and distribution to accelerate diagnostics, AI, insurance, and wellness innovation in the $250B+ global pet economy.
New Product of The Year Awards and Guided Exhibit Floor Tours to Headline the 2025 Assembly Show
Attendees Invited to Vote on the Industry's Top Innovations
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell death through iron-dependent regulation.
Bausch Health Announces Results of Special Meeting of Shareholders
LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025 (the "Rights Plan Agreement"), as described in detail in the Company's Management Proxy Circular and Proxy Statement dated August 27, 2025.
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities
EX DEA Administrator Anne Milgram's "Swampy" Legacy: No-Bid Contracts, No Marijuana Reform, and No Accountability
MMJ BioPharma CEO Duane Boise summed it up bluntly:"Milgram's DEA was a monument to incompetence and indifference - and patients paid the price. Every day of delay meant another day people with Huntington's and Multiple Sclerosis went without hope. Terry Cole now has the chance to fix what she broke."
KFC’s Secret Recipe is Out - The One the World Really Needs
JOHANNESBURG, ZA / ACCESS Newswire / October 9, 2025 / KFC Africa's ( http://KFC.co.za ) big secret is out, and no, it's not the blend of 11 herbs and spices, it's a recipe of hope to end child hunger - open-sourced globally for sharing and scaling in honour of World Food Day.
BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis
VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, today announced that it has completed a Track One priority patent filing with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual thin-film cladribine formulation (BNT23001), designed for the treatment of multiple sclerosis (MS). The Track One patent filing also covers sublingual drug products for the treatment of many other neurological autoimmune diseases, including myasthenia gravis and lupus nephritis.
Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Termination of Initial Transaction, Subscription of New Ordinary Shares, Warrant Issue and PDMR Dealings
Suspect in US court months after deadly Los Angeles fire
A man suspected of deliberately causing one of the deadliest fires in US history appeared in court Wednesday charged with sparking a blaze that tore through Los Angeles in January.
Man arrested over deadly January fire in Los Angeles
Authorities investigating one of the deadly fires that tore through Los Angeles in January said Wednesday they had arrested a man they believe deliberately started the blaze.
Gisele Pelicot urges accused rapist to 'take responsibility'
Gisele Pelicot, the Frenchwoman who became a feminist hero in a mass rape trial last year, was thrust into the national spotlight once again Wednesday, telling the one man who still denies raping her he must "take responsibility" for his actions.